Opioids: FDA Eyes Better Prescriber Education, But Academics Urge Promotion Crackdown

US agency is convening two-day workshop on federal efforts to support healthcare provider education about pain management and safe use of the drugs; two University of Washington researchers say agency needs to exercise stricter oversight of opioid marketing and promotion.

Watch gears up close

FDA’s recent efforts to combat opioid-related adverse events, abuse and death include revisiting some old ideas, such as prescriber education, risk management plans and labeling changes.

However, two University of Washington researchers are making the case for a new and heightened level of agency oversight of...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Drug Safety

More from Pink Sheet